Medicare Enrolled

Dr. Ron Yamane, M.D.

Internal Medicine · Gardena, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1300 W 155TH ST, Gardena, CA 90247
3103276400
In practice since 2006 (19 years)
NPI: 1649383308 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yamane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yamane? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yamane

Dr. Ron Yamane is an internal medicine specialist in Gardena, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Yamane performed 1,559 Medicare services across 627 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yamane received a total of $4,951 from 24 pharmaceutical and/or device companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yamane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 21% volume in CA $4,951 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,559
Medicare services
Top 21% in CA for internal medicine
627
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~82 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
716 $65 $150
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
610 $8 $15
Quadrivalent influenza vaccine, cell-culture derived
A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics.
80 $33 $40
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
80 $33 $35
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
50 $12 $65
Stool test for blood to screen for colon tumors
A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors.
12 $4 $20
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
11 $64 $180
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,951
Total received (2018-2024)
Avg $707/year across 7 years
Top 16% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
208
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,951 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$199
2023
$717
2022
$904
2021
$739
2020
$401
2019
$1,358
2018
$632

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$102
Lilly USA, LLC
$51
Novo Nordisk Inc
$24
Janssen Pharmaceuticals, Inc
$22
Top 3 companies account for 88.7% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$914
Amgen Inc.
$801
AstraZeneca Pharmaceuticals LP
$522
Novo Nordisk Inc
$449
Radius Health, Inc.
$292
Amarin Pharma Inc.
$273
Lilly USA, LLC
$256
Esperion Therapeutics, Inc.
$184
GlaxoSmithKline, LLC.
$183
Boehringer Ingelheim Pharmaceuticals, Inc.
$170
Merck Sharp & Dohme Corporation
$157
Novartis Pharmaceuticals Corporation
$136
PFIZER INC.
$126
Almatica Pharma LLC
$100
Alexion Pharmaceuticals, Inc.
$68
Horizon Therapeutics plc
$67
Eisai Inc.
$41
Hikma Pharmaceuticals USA
$41
Avanir Pharmaceuticals, Inc.
$40
Astellas Pharma US Inc
$38
Regeneron Healthcare Solutions, Inc.
$31
Alnylam Pharmaceuticals Inc.
$22
Biogen, Inc.
$20
Azurity Pharmaceuticals, Inc.
$19
Top 3 companies account for 45.2% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AREXVY · Aimovig · CHANTIX · DUEXIS · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · GRALISE · Horizant · INVOKANA · JANUVIA · KRYSTEXXA · LOREEV XR · MOUNJARO · Mitigare · NEXLETOL · NEXLIZET · NUEDEXTA · ONPATTRO · Otezla · Ozempic · PENNSAID · PRALUENT ALIROCUMAB INJECTION · Prolia · Repatha · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Soliris · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Tymlos · VESICARE · Vascepa · Victoza · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an internal medicine specialist in Gardena?
Compare internal medicine physicians in the Gardena area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
4,945
Per 100K population
50.2
County median income
$87,760
Nearest hospital
MEMORIAL HOSPITAL OF GARDENA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yamane is a clinical cardiology specialist, with above-average Medicare volume (top 21% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yamane experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Yamane performed 716 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yamane receive payments from pharmaceutical companies?
Yes. Dr. Yamane received a total of $4,951 from 24 companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yamane's costs compare to other internal medicine physicians in Gardena?
Dr. Yamane's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yamane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →